Celltrion
068270.KS
#811
Rank
NZ$49.60 B
Marketcap
NZ$220.58
Share price
2.07%
Change (1 day)
14.84%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Dividend history for Celltrion (068270.KS)

Celltrion (stock symbol: 068270.KS) made a total of 9 dividend payments.
The sum of all dividends (adjusted for stock splits) is : NZ$2.81
Dividend yield (TTM) : 0.37% See Celltrion dividend yield history

Dividend payments for Celltrion (068270.KS) from 2006 to 2024

Annual dividend payments

Year Dividend (stock split adjusted) Change
2024 NZ$0.81 50.00%
2023 NZ$0.54 33.33%
2022 NZ$0.41-48.00%
2021 NZ$0.78 3,764.42%
2012 NZ$0.02022-77.75%
2011 NZ$0.09088 33.33%
2010 NZ$0.06816 50.00%
2007 NZ$0.04544N/A
2006 NZ$0.04544N/A

List of all dividend payments

Date Dividend (stock split adjusted) Change
2024-12-27NZ$0.81 50.00%
2023-12-27NZ$0.54 33.33%
2022-12-28NZ$0.41-48.00%
2021-12-29NZ$0.78 3,764.42%
2012-12-27NZ$0.02022-77.75%
2011-12-28NZ$0.09088 33.33%
2010-12-29NZ$0.06816 50.00%
2007-12-27NZ$0.04544N/A
2006-12-27NZ$0.04544N/A